Troy Dean Myers, O.D.
Optometrist · Glendive, MT
Troy Dean Myers, O.D. is an optometrist with a practice address in Glendive, Montana, and NPI 1497914998, issued on Jun 9, 2008. Check the license (Montana 797, as entered in NPPES) with the Montana board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Troy Dean Myers
- Credential
- O.D.
- Primary taxonomy
- Optometrist 152W00000X
- License number
- 797 MT
Self-reported in NPPES; status is on the state search - Practice location
- 115 W Valentine St, Glendive, MT 59330
- Phone
- (406) 365-8231
- Enumerated
- Jun 9, 2008
- Record last updated
- Jul 15, 2010 (not updated in 16 years: call before relying on the address or phone)
- Fax
- (406) 365-7081
- Medicare enrollment
- Enrolled (PECOS I20080731000301); accepts Medicare assignment
- Medical or professional school
- Illinois College Of Optometry At Chicago, 2007
- Entity
- Type 1 · individual
8 nearest optometrist records → All 245 in Montana → Look up another NPI →
Verify Troy Dean Myers in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Montana board licenses this profession
Search for license 797Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.9 times the Medicare Part D claims of the average optometrist in 2024
815 Medicare Part D claims for 162 beneficiaries, against an average of 277 among the 33,128 providers of this specialty who prescribed in Part D. Brand-name drugs were 51% of claims.
Most prescribed
- Latanoprost395 claims
- Timolol Maleate70 claims
- Brimonidine Tartrate65 claims
- Dorzolamide-Timolol57 claims
- Prednisolone Acetate27 claims
- Dorzolamide Hcl22 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 100 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $31.29
1 payment: food and beverage; the largest payer was Alcon Vision LLC. The 34,453 providers of this specialty with any payment received $769.99 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Troy Dean Myers among 245 optometrist records in Montana
Troy Dean Myers, O.D. is one of 245 optometrist records with a practice address in Montana. 75% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2008, is newer than 57% of them.
- NPI issued2008 · 57% of these records are older, 38% newer
- In a Medicare fileYes · 75% of these records are
- In the CMS Doctors and Clinicians fileYes · 65% of these records are
- Graduated2007 · median 2008 among the 160 with a school on file
- Record last updated2010 · 61% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 152W00000X and a Montana practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
2 optometrist records list a practice address in Glendive
They are 2 of the 98 NPPES records with a practice address in Glendive, and 245 optometrist records in Montana.
All 245 in Montana → Every provider in Glendive → Optometrist nationwide →
The 8 optometrist records with the nearest ZIP codes
- K ZuroffGlendive, MT 593301831177328
- Lynn Carlo, O DMiles City, MT 593011205801776
- Robert Lunde, O DMiles City, MT 593011427023522
- Laurel Schimelfening, OD, MEDVFLMiles City, MT 593011376035493
- Albert Sparr, O DMiles City, MT 593011629043732
- Ashley WatsonMiles City, MT 593011043673189
- Roger Anderson, ODSidney, MT 592701740345776
- Matthew Biwer, ODSidney, MT 592701619129111
Common questions
What is Troy Dean Myers, O.D.'s NPI number?
Troy Dean Myers, O.D.'s National Provider Identifier (NPI) is 1497914998, issued on Jun 9, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Troy Dean Myers, O.D. located?
The NPPES record lists a practice address at 115 W Valentine St, Glendive, MT, 59330. Phone: (406) 365-8231. Providers update this record themselves, so call before visiting.
How can I verify Troy Dean Myers, O.D.'s license?
NPPES lists Montana license number 797, as entered by the provider. Search the Montana board that licenses this profession; the NPPES record confirms identity only.
How much does Troy Dean Myers, O.D. prescribe under Medicare Part D?
In 2024, Troy Dean Myers, O.D. had 815 Medicare Part D claims for 162 beneficiaries; the average among optometrist prescribers was 277. Part D covers Medicare prescriptions only.
What is Troy Dean Myers, O.D.'s MIPS final score?
The 2023 MIPS final score is 100 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.